CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNY

Topical tacrolimus or pimecrolimus

Phase 3
Sanofi (SNY)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
SNYPhase 3

Amlitelimab Phase 3 Est. Readout

Topical tacrolimus or pimecrolimus
Q3 2027~QSTALE
CT.gov
00%
Competitive Landscape

0 competitors in Dermatitis Atopic

View Full Landscape
Drug Information

Target Indication

Dermatitis Atopic

Clinical Trial

NCT06241118

Last updated: 3/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.